Deccan Cements Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 6, 2026, 2:18 am

Market Cap	980 Cr.
Current Price	696
Intrinsic Value	₹80.53
High / Low	1,184/593
Stock P/E	30.8
Book Value	533
Dividend Yield	0.09 %
ROCE	1.53 %
ROE	0.75 %
Face Value	5.00
PEG Ratio	-1.68

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Deccan Cements Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Deccan Cements Ltd	980 Cr.	696	1,184/593	30.8	533	0.09 %	1.53 %	0.75 %	5.00
Shree Digvijay Cement Co. Ltd	968 Cr.	65.5	108/61.0	27.4	24.7	2.29 %	8.73 %	6.77 %	10.0
NCL Industries Ltd	815 Cr.	180	239/172	12.3	198	1.66 %	6.71 %	3.41 %	10.0
Andhra Cements Ltd	484 Cr.	52.7	110/48.2		8.27	0.00 %	10.5 %	68.4 %	10.0
Anjani Portland Cement Ltd	361 Cr.	122	161/96.0		69.9	0.00 %	9.07 %	31.8 %	10.0
Industry Average	38,086.80 Cr	1,841.74		293.47	573.87	0.63%	8.92%	85.54%	7.13

All Competitor Stocks of Deccan Cements Ltd

Quarterly Result

Metric	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	180.46	211.13	195.94	192.08	167.25	216.86	223.24	172.15	120.46	115.45	118.92	150.56	140.31
Expenses	163.64	186.08	175.42	166.86	153.55	188.28	196.93	160.83	118.27	106.70	105.80	122.68	120.15
Operating Profit	16.82	25.05	20.52	25.22	13.70	28.58	26.31	11.32	2.19	8.75	13.12	27.88	20.16
OPM %	9.32%	11.86%	10.47%	13.13%	8.19%	13.18%	11.79%	6.58%	1.82%	7.58%	11.03%	18.52%	14.37%
Other Income	1.74	1.68	3.14	3.15	3.67	4.28	-11.43	3.02	2.89	3.31	6.98	2.74	2.32
Interest	2.71	3.30	3.50	2.42	2.86	3.83	3.27	3.02	3.41	3.51	2.81	3.47	3.27
Depreciation	6.90	6.89	6.78	6.81	6.92	6.96	6.94	7.01	7.11	7.07	6.89	6.68	6.74
Profit before tax	8.95	16.54	13.38	19.14	7.59	22.07	4.67	4.31	-5.44	1.48	10.40	20.47	12.47
Tax %	26.59%	26.48%	26.08%	26.12%	37.55%	30.31%	35.76%	34.80%	-25.92%	45.27%	23.65%	24.96%	27.19%
Net Profit	6.57	12.16	9.90	14.14	4.73	15.39	3.01	2.81	-4.04	0.81	7.95	15.35	9.07
EPS in Rs	4.69	8.68	7.07	10.09	3.38	10.99	2.15	2.01	-2.88	0.58	5.68	10.96	6.48

Last Updated: January 1, 2026, 11:32 pm

Below is a detailed analysis of the quarterly data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Sales, as of Sep 2025, the value is 140.31 Cr.. The value appears to be declining and may need further review. It has decreased from 150.56 Cr. (Jun 2025) to 140.31 Cr., marking a decrease of 10.25 Cr..
For Expenses, as of Sep 2025, the value is 120.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 122.68 Cr. (Jun 2025) to 120.15 Cr., marking a decrease of 2.53 Cr..
For Operating Profit, as of Sep 2025, the value is 20.16 Cr.. The value appears to be declining and may need further review. It has decreased from 27.88 Cr. (Jun 2025) to 20.16 Cr., marking a decrease of 7.72 Cr..
For OPM %, as of Sep 2025, the value is 14.37%. The value appears to be declining and may need further review. It has decreased from 18.52% (Jun 2025) to 14.37%, marking a decrease of 4.15%.
For Other Income, as of Sep 2025, the value is 2.32 Cr.. The value appears to be declining and may need further review. It has decreased from 2.74 Cr. (Jun 2025) to 2.32 Cr., marking a decrease of 0.42 Cr..
For Interest, as of Sep 2025, the value is 3.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.47 Cr. (Jun 2025) to 3.27 Cr., marking a decrease of 0.20 Cr..
For Depreciation, as of Sep 2025, the value is 6.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.68 Cr. (Jun 2025) to 6.74 Cr., marking an increase of 0.06 Cr..
For Profit before tax, as of Sep 2025, the value is 12.47 Cr.. The value appears to be declining and may need further review. It has decreased from 20.47 Cr. (Jun 2025) to 12.47 Cr., marking a decrease of 8.00 Cr..
For Tax %, as of Sep 2025, the value is 27.19%. The value appears to be increasing, which may not be favorable. It has increased from 24.96% (Jun 2025) to 27.19%, marking an increase of 2.23%.
For Net Profit, as of Sep 2025, the value is 9.07 Cr.. The value appears to be declining and may need further review. It has decreased from 15.35 Cr. (Jun 2025) to 9.07 Cr., marking a decrease of 6.28 Cr..
For EPS in Rs, as of Sep 2025, the value is 6.48. The value appears to be declining and may need further review. It has decreased from 10.96 (Jun 2025) to 6.48, marking a decrease of 4.48.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 9:16 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	441	407	625	496	570	651	555	758	792	782	799	527	541
Expenses	383	343	511	396	484	556	477	582	630	684	704	492	468
Operating Profit	57	64	115	100	86	95	79	176	162	97	96	35	73
OPM %	13%	16%	18%	20%	15%	15%	14%	23%	20%	12%	12%	7%	13%
Other Income	2	3	1	2	3	10	-0	10	-8	9	-2	16	14
Interest	27	27	15	7	6	8	7	8	10	13	13	13	15
Depreciation	24	19	20	22	23	22	21	23	26	27	28	28	28
Profit before tax	7	21	81	74	61	75	51	155	117	67	53	11	43
Tax %	33%	6%	43%	36%	37%	39%	-12%	26%	25%	26%	30%	30%
Net Profit	5	20	46	47	39	46	57	115	88	49	37	8	32
EPS in Rs	3.59	14.20	32.54	33.48	27.52	32.88	40.44	82.19	62.52	35.20	26.60	5.38	22.73
Dividend Payout %	17%	9%	8%	9%	11%	11%	10%	6%	8%	11%	11%	11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	300.00%	130.00%	2.17%	-17.02%	17.95%	23.91%	101.75%	-23.48%	-44.32%	-24.49%	-78.38%
Change in YoY Net Profit Growth (%)	0.00%	-170.00%	-127.83%	-19.20%	34.97%	5.96%	77.84%	-125.23%	-20.84%	19.83%	-53.89%

Deccan Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	3%
5 Years:	-1%
3 Years:	-13%
TTM:	-35%

Compounded Profit Growth
10 Years:	-9%
5 Years:	-35%
3 Years:	-58%
TTM:	-51%

Stock Price CAGR
10 Years:	17%
5 Years:	31%
3 Years:	28%
1 Year:	71%

Return on Equity
10 Years:	11%
5 Years:	10%
3 Years:	5%
Last Year:	1%

Last Updated: September 5, 2025, 2:45 am

Balance Sheet

Last Updated: December 4, 2025, 1:09 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	7	7	7	7	7	7	7	7	7	7	7	7	7
Reserves	223	238	279	325	358	399	443	558	639	680	712	715	739
Borrowings	239	191	79	70	33	54	106	104	166	265	520	714	760
Other Liabilities	119	114	127	132	161	161	155	193	173	202	207	189	194
Total Liabilities	588	550	493	535	560	621	710	861	985	1,155	1,446	1,625	1,700
Fixed Assets	373	356	342	377	363	354	378	446	453	440	423	402	389
CWIP	35	33	34	0	4	9	62	12	21	241	514	805	895
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	180	161	116	157	192	258	271	404	511	474	509	417	416
Total Assets	588	550	493	535	560	621	710	861	985	1,155	1,446	1,625	1,700

Below is a detailed analysis of the balance sheet data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
For Reserves, as of Sep 2025, the value is 739.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 24.00 Cr..
For Borrowings, as of Sep 2025, the value is 760.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 714.00 Cr. (Mar 2025) to 760.00 Cr., marking an increase of 46.00 Cr..
For Other Liabilities, as of Sep 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 5.00 Cr..
For Total Liabilities, as of Sep 2025, the value is 1,700.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
For Fixed Assets, as of Sep 2025, the value is 389.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 389.00 Cr., marking a decrease of 13.00 Cr..
For CWIP, as of Sep 2025, the value is 895.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2025) to 895.00 Cr., marking an increase of 90.00 Cr..
For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
For Other Assets, as of Sep 2025, the value is 416.00 Cr.. The value appears to be declining and may need further review. It has decreased from 417.00 Cr. (Mar 2025) to 416.00 Cr., marking a decrease of 1.00 Cr..
For Total Assets, as of Sep 2025, the value is 1,700.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..

However, the Borrowings (760.00 Cr.) are higher than the Reserves (739.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	66	67	140	61	71	58	43	197	84	55	57	-38
Cash from Investing Activity +	-0	-2	-7	-27	-12	-14	-90	-45	-92	-219	-277	-227
Cash from Financing Activity +	-63	-82	-125	-15	-36	10	32	-9	45	80	238	178
Net Cash Flow	2	-17	9	19	23	55	-15	143	38	-85	18	-87

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-182.00	-127.00	36.00	30.00	53.00	41.00	-27.00	72.00	-4.00	-168.00	-424.00	-679.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	22	27	5	8	9	9	31	12	11	13	25	40
Inventory Days	935	712	397	464	364	374	493	341	349	601	408	541
Days Payable	164	152	150	25	16	27	169	218	132	291	164	194
Cash Conversion Cycle	793	587	251	446	357	356	355	135	227	323	268	386
Working Capital Days	27	15	-2	3	22	10	1	-34	-51	-32	-45	-65
ROCE %	7%	11%	24%	21%	17%	19%	13%	27%	20%	9%	8%	2%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%	56.24%
FIIs	9.28%	9.40%	9.24%	10.07%	10.82%	10.94%	11.87%	11.55%	10.30%	9.91%	9.93%	12.85%
DIIs	0.49%	0.49%	0.49%	0.49%	0.65%	0.97%	0.78%	0.78%	0.78%	0.78%	0.90%	0.78%
Public	33.99%	33.87%	34.01%	33.19%	32.28%	31.85%	31.10%	31.42%	32.67%	33.06%	32.92%	30.11%
No. of Shareholders	17,046	16,449	15,807	14,876	14,118	13,911	13,420	12,679	11,935	11,529	11,952	11,314

Shareholding Pattern Chart

No. of Shareholders

Deccan Cements Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25
FaceValue	5.00
Basic EPS (Rs.)	5.37
Diluted EPS (Rs.)	5.37
Cash EPS (Rs.)	25.41
Book Value[Excl.RevalReserv]/Share (Rs.)	515.74
Book Value[Incl.RevalReserv]/Share (Rs.)	515.74
Revenue From Operations / Share (Rs.)	376.21
PBDIT / Share (Rs.)	36.81
PBIT / Share (Rs.)	16.77
PBT / Share (Rs.)	7.67
Net Profit / Share (Rs.)	5.37
NP After MI And SOA / Share (Rs.)	5.37
PBDIT Margin (%)	9.78
PBIT Margin (%)	4.45
PBT Margin (%)	2.03
Net Profit Margin (%)	1.42
NP After MI And SOA Margin (%)	1.42
Return on Networth / Equity (%)	1.04
Return on Capital Employeed (%)	1.76
Return On Assets (%)	0.46
Long Term Debt / Equity (X)	0.75
Total Debt / Equity (X)	0.98
Current Ratio (X)	1.17
Quick Ratio (X)	0.82
Dividend Payout Ratio (NP) (%)	55.89
Dividend Payout Ratio (CP) (%)	11.80
Earning Retention Ratio (%)	44.11
Cash Earning Retention Ratio (%)	88.20
Interest Coverage Ratio (X)	4.04
Interest Coverage Ratio (Post Tax) (X)	1.59
Enterprise Value (Cr.)	1670.92
EV / Net Operating Revenue (X)	3.17
EV / EBITDA (X)	32.40
MarketCap / Net Operating Revenue (X)	2.09
Retention Ratios (%)	44.10
Price / BV (X)	1.52
Price / Net Operating Revenue (X)	2.09
EarningsYield	0.01

After reviewing the key financial ratios for Deccan Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. No previous period data is available for comparison.
For Basic EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
For Diluted EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
For Cash EPS (Rs.), as of Mar 25, the value is 25.41. This value is within the healthy range. No previous period data is available for comparison.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 376.21. No previous period data is available for comparison.
For PBDIT / Share (Rs.), as of Mar 25, the value is 36.81. This value is within the healthy range. No previous period data is available for comparison.
For PBIT / Share (Rs.), as of Mar 25, the value is 16.77. This value is within the healthy range. No previous period data is available for comparison.
For PBT / Share (Rs.), as of Mar 25, the value is 7.67. This value is within the healthy range. No previous period data is available for comparison.
For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
For PBDIT Margin (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For PBIT Margin (%), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For PBT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Net Profit Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 8. No previous period data is available for comparison.
For Return on Networth / Equity (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 15. No previous period data is available for comparison.
For Return on Capital Employeed (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Return On Assets (%), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. No previous period data is available for comparison.
For Total Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. No previous period data is available for comparison.
For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. No previous period data is available for comparison.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.89. This value exceeds the healthy maximum of 50. No previous period data is available for comparison.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.80. This value is below the healthy minimum of 20. No previous period data is available for comparison.
For Earning Retention Ratio (%), as of Mar 25, the value is 44.11. This value is within the healthy range. No previous period data is available for comparison.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.20. This value exceeds the healthy maximum of 70. No previous period data is available for comparison.
For Interest Coverage Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. No previous period data is available for comparison.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Enterprise Value (Cr.), as of Mar 25, the value is 1,670.92. No previous period data is available for comparison.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
For EV / EBITDA (X), as of Mar 25, the value is 32.40. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
For Retention Ratios (%), as of Mar 25, the value is 44.10. This value is within the healthy range. No previous period data is available for comparison.
For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Deccan Cements Ltd as of March 10, 2026 is: ₹98.59

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 10, 2026, Deccan Cements Ltd is Overvalued by 85.83% compared to the current share price ₹696.00

Intrinsic Value of Deccan Cements Ltd as of March 10, 2026 is: ₹80.53

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 10, 2026, Deccan Cements Ltd is Overvalued by 88.43% compared to the current share price ₹696.00

Last 5 Year EPS CAGR: -18.32%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -12.58, which is a positive sign. The company has higher reserves (485.23 cr) compared to borrowings (253.92 cr), indicating strong financial stability. The company has shown consistent growth in sales (611.08 cr) and profit (62.77 cr) over the years.	The stock has a low average ROCE of 14.83%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 373.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Cements Ltd:
1. Net Profit Margin: 1.42%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 1.76% (Industry Average ROCE: 8.92%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 1.04% (Industry Average ROE: 85.54%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 1.59
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.82
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 30.8 (Industry average Stock P/E: 293.47)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.98
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Deccan Cements Ltd. is a Public Limited Listed company incorporated on 31/07/1979 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L26942TG1979PLC002500 and registration number is 002500. Currently Company is involved in the business activities of Manufacture of clinkers and cement. Company's Total Operating Revenue is Rs. 526.98 Cr. and Equity Capital is Rs. 7.00 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Cement	Deccan Chambers, Hyderabad Telangana 500082	Contact not found

Management
Name	Position Held
Ms. P Parvathi	Chairperson & Managing Director
Mr. S Venkateswarlu	Whole Time Director
Mrs. Mahpara Ali	Director
Mr. Paturi Srinivasa Rao	Director
Mr. Srivari Chandrasekhar	Director
Mr. Rabindra Srikantan	Director

FAQ

What is the intrinsic value of Deccan Cements Ltd?

Deccan Cements Ltd's intrinsic value (as of 10 March 2026) is ₹80.53 which is 88.43% lower the current market price of ₹696.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹980 Cr. market cap, FY2025-2026 high/low of ₹1,184/593, reserves of ₹739 Cr, and liabilities of ₹1,700 Cr.

What is the Market Cap of Deccan Cements Ltd?

The Market Cap of Deccan Cements Ltd is 980 Cr..

What is the current Stock Price of Deccan Cements Ltd as on 10 March 2026?

The current stock price of Deccan Cements Ltd as on 10 March 2026 is ₹696.

What is the High / Low of Deccan Cements Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Deccan Cements Ltd stocks is ₹1,184/593.

What is the Stock P/E of Deccan Cements Ltd?

The Stock P/E of Deccan Cements Ltd is 30.8.

What is the Book Value of Deccan Cements Ltd?

The Book Value of Deccan Cements Ltd is 533.

What is the Dividend Yield of Deccan Cements Ltd?

The Dividend Yield of Deccan Cements Ltd is 0.09 %.

What is the ROCE of Deccan Cements Ltd?

The ROCE of Deccan Cements Ltd is 1.53 %.

What is the ROE of Deccan Cements Ltd?

The ROE of Deccan Cements Ltd is 0.75 %.

What is the Face Value of Deccan Cements Ltd?

The Face Value of Deccan Cements Ltd is 5.00.